Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Post-Traumatic Osteoarthritis: Managing OA That Develops After Joint Injuries & Reconstructive Surgery

Susan Bernstein  |  Issue: February 2019  |  November 28, 2018

MRI is a potentially powerful tool to identify proteoglycan and collagen loss, both possibly meaningful changes seen early after joint injury.

“We have to prevent collagen loss, because that occurs early on. There is a narrow window, but I think we can prevent a lot of the OA afterward,” he concluded. Proteomic analysis may tell us about gene markers that predict who is likely to develop post-traumatic OA after surgery and reveal more clues on why some people resolve their inflammation while others do not.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Susan Bernstein is a freelance medical journalist based in Atlanta.

References

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  1. Brown TD, Johnston RC, Saltzman CL, et al. Posttraumatic osteoarthritis: A first estimate of incidence, prevalence and burden of disease. J Orthop Trauma. 2006 Nov–Dec;20(10):739–744.
  2. Anderson DD, Van Hofwegen C, Marsh JL, et al. Is elevated contact stress predictive of post-traumatic osteoarthritis for imprecisely reduced tibial plafond fractures? J Orthop Res. 2011 Jan;29(1):31–39.
  3. Sward P, Frobell R, Englund M, et al. Cartilage and bone markers and inflammatory cytokines are increased in synovial fluid in the acute phase of knee injury (hemarthrosis): A cross-sectional analysis. Osteoarthritis Cartilage. 2012 Nov;20(11):1303–1308.
  4. Elsaid KA, Fleming BC, Oksendahl HL, et al. Decreased lubricin concentrations and markers of joint inflammation in synovial fluids from patients with anterior cruciate ligament injury. Arthritis Rheum. 2008 Jun;58(6):1707–1715.
  5. Lewis JS, Hembree WC, Furman BD, et al. Acute joint pathology and synovial inflammation is associated with increased intra-articular fracture severity in the mouse knee. Osteoarthritis Cartilage. 2011 Jul;19(7):864–873.
  6. Wu P, Holguin N, Silva MJ, et al. Early response of mouse joint tissue to noninvasive knee injury suggests treatment targets. Arthritis Rheumatol. 2014 May;66(5):1256–1265.
  7. Borsiczky B, Fodor B, Rácz B, et al. Rapid leukocyte activation following intraarticular bleeding. J Orthop Res. 2006 April;24(4):684–689.
  8. Van Meegeren ME, Roosendahl G, Mastbergen SC, et al. Blood-induced joint damage: The devastating effects of acute joint bleeds versus micro-bleeds. Cartilage. 2013 Oct;4(4):313–320.
  9. Haslauer CM, Elsaid KA, Fleming BC, et al. Loss of extracellular matrix from articular cartilage is mediated by the synovium and ligament after anterior cruciate ligament injury. Osteoarthritis Cartilage. 2013 Dec;21(12):1950–1957.
  10. Fang H, Huang L, Welch I, et al. Early changes of articular cartilage and subchondral bone in the DMM mouse model of osteoarthritis. Sci Rep. 2018 Feb 12;8(1):2855.
  11. Zhang RK, Fang H, Chen YX, et al. Gene expression analyses of subchondral bone in early experimental osteoarthritis by microarray. PLoS One. 2012 Feb;7(2):e32356.
  12. Wei T, Kulkarni NH, Zeng QQ ,et al. Analysis of early changes in the articular cartilage transcriptisome in the rat meniscal tear model of osteoarthritis: pathway comparisons with the rat anterior cruciate transection model and with human osteoarthritic cartilage. Osteoarthritis Cartilage. 2010 Jul;18(7):992–1000.
  13. Appleton CTG, Pitelka V, Beier HF. Global analyses of gene expression in early experimental osteoarthritis. Arthritis Rheum. 2007 Jun;56(6):1854–1868.
  14. Longobardi L, Temple JD, Tagliaferro L, et al. Role of the C-C chemokine receptor 2 in a murine model of injury-induced osteoarthritis. Osteoarthritis Cartilage. 2017 Jun;25(6):914–925.
  15. Harris KP, Driban JB, Sitler MR, et al. Tibiofemoral osteoarthritis after surgical or nonsurgical treatment of anterior cruciate ligament rupture: A systematic review. J Athl Train. 2017 Jun 2;52(6):507–517.
  16. Frobell RB. Change in cartilage thickness, posttraumatic bone marrow lesions, and joint fluid volumes after acute ACL disruption: A two-year prospective MRI study of sixty-one subjects. J Bone Joint Surg Am. 2011 Jun;93(12):1096–1103.
  17. Knox J, Pedoia V, Wang A, et al. Longitudinal changes in MR T1p/T2 signal of meniscus and its association with cartilage T1p/T2 in ACL-injured patients. Osteoarthritis Cartilage. 2018 May;26(5):689–696.
  18. Eckstein F, Collins JE, Nevitt MC, et al. Brief report: Cartilage thickness change as an imaging biomarker of knee osteoarthritis progression: Data from the Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium. Arthritis Rheumatol. 2015 Dec;67(12):3184–3189.
  19. Driban JB, Price LL, Lo GH, et al. Evaluation of bone marrow lesion volume as a knee osteoarthritis biomarker—longitudinal relationships with pain and structural changes: Data from the Osteoarthritis Initiative. Arthritis Res Ther. 2013;15(5):R112.
  20. Pietrosimone B, Lepley AS, Harkey MS, et al. Quadriceps strength predicts self-reported function post-ACL reconstruction. Med Sci Sports Exerc. 2016 Sep;48(9):1671–1677.
  21. Macias-Hernandez SI, Morones-Alba JD, Miranda-Duarte A, et al. Glenohumeral osteoarthritis: Overview, therapy and rehabilitation. Disabil Rehabil. 2017 Aug;39(16):1674–1682.
  22. Lepley LK, Wojtys EM, Palmieri-Smith RM. Combination of eccentric exercise and neuromuscular electric stimulation to improve quadriceps function post-ACL reconstruction. Knee. 2015 Jun;22(3):270–277.
  23. MOON Knee Group, Spindler KP, Huston LJ, et al. Ten-year outcomes and risk factors after anterior cruciate ligament reconstruction: A MOON longitudinal prospective cohort study. Am J Sports Med. 2018 Mar;46(4):815–825.
  24. Wasserstein D, Huston LJ, Nwosu S, et al. KOOS pain as a marker for significant knee pain two and six years after primary ACL reconstruction: A Multicenter Orthopaedic Outcomes Network (MOON) prospective longitudinal cohort study. Osteoarthritis Cartilage. 2015 Oct;23(10):1674–1684.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:American College of RheumatologyConditionsMeeting ReportsOsteoarthritis and Bone Disorders Tagged with:2018 ACR/ARHP Annual Meeting

Related Articles

    Antiphospholipid Antibody Testing Update

    January 13, 2012

    Successes, challenges, and controversies of diagnostic methods for APS

    Basics of Biologic Joint Reconstruction

    April 6, 2012

    For young patients especially, this can delay knee replacement and provide better outcomes.

    New Therapeutics for Osteoarthritis May Be in Sight

    April 1, 2015

    Overview of OA pathogenesis, recent discoveries suggest new treatment strategies are possible

    Emerging Treatments for OA: New Therapies Target Joint Pain, Not Just Structural Damage

    November 28, 2018

    CHICAGO—Are effective treatments for osteoarthritis (OA) on the horizon? In Emerging Treatments for Osteoarthritis at the 2018 ACR/ARHP Annual Meeting, experts discussed potential therapies to address OA structural progression, pain and inflammation. With an aging population and rising obesity rates, “we can expect the prevalence of osteoarthritis will only increase,” said Anne-Marie Malfait, MD, PhD,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences